MedTrace Logo

Heterozygous Individuals for AGXT and Kidney Stones

NCT04430426 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2026-07-20

No results posted yet for this study

Summary

This study seeks to examine the effects of a heterozygous mutation of the AGXT gene in a stone forming population on endogenous oxalate production. Participants will consume a controlled low-oxalate diet and provide blood and urine samples to measure the amount of oxalate in their bodies.

Conditions

  • Kidney Stone
  • Urolithiasis, Calcium Oxalate

Interventions

OTHER

Controlled Diet

Participants will consume a controlled low oxalate diet for five days.

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Kyle Wood, MD · University of Alabama at Birmingham

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-07-01
Primary Completion
2031-08-01
Completion
2032-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04430426 on ClinicalTrials.gov